BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aversa A, La Vignera S, Rago R, Gambineri A, Nappi RE, Calogero AE, Ferlin A. Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions. Front Endocrinol (Lausanne) 2020;11:516. [PMID: 32849300 DOI: 10.3389/fendo.2020.00516] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 12.7] [Reference Citation Analysis]
Number Citing Articles
1 Makhdoomi MJ, Shah IA, Rashid R, Rashid A, Singh S, Shah ZA, Ganie MA. Effect Modification of LHCGR Gene Variant (rs2293275) on Clinico-Biochemical Profile, and Levels of Luteinizing Hormone in Polycystic Ovary Syndrome Patients. Biochem Genet 2023. [PMID: 36633772 DOI: 10.1007/s10528-022-10327-z] [Reference Citation Analysis]
2 Li X, Wang C, Yang H, Pei D, Liu Y, Yan S, Li Y. Screening and verification of genes related to polycystic ovary syndrome. J Int Med Res 2023;51:3000605221147444. [PMID: 36628439 DOI: 10.1177/03000605221147444] [Reference Citation Analysis]
3 Panchal D, Pandya T, Kevlani V, Shah S, Acharya S. Development and evaluation of Novel krill oil based Clomiphene Microemulsion as a therapeutic strategy for PCOS treatment.. [DOI: 10.21203/rs.3.rs-2339375/v1] [Reference Citation Analysis]
4 Ionescu OM, Frincu F, Mehedintu A, Plotogea M, Cirstoiu M, Petca A, Varlas V, Mehedintu C. Berberine-A Promising Therapeutic Approach to Polycystic Ovary Syndrome in Infertile/Pregnant Women. Life (Basel) 2023;13. [PMID: 36676074 DOI: 10.3390/life13010125] [Reference Citation Analysis]
5 Khant Aung Z, Masih RR, Desroziers E, Campbell RE, Brown RSE. Enhanced pup retrieval behaviour in a mouse model of polycystic ovary syndrome. J Neuroendocrinol 2022;34:e13206. [PMID: 36416198 DOI: 10.1111/jne.13206] [Reference Citation Analysis]
6 Choudhury AA, Rajeswari VD. Polycystic ovary syndrome (PCOS) increases the risk of subsequent gestational diabetes mellitus (GDM): A novel therapeutic perspective. Life Sciences 2022;310:121069. [DOI: 10.1016/j.lfs.2022.121069] [Reference Citation Analysis]
7 Di Luigi L, Greco EA, Fossati C, Aversa A, Sgrò P, Antinozzi C. Clinical Concerns on Sex Steroids Variability in Cisgender and Transgender Women Athletes. Int J Sports Med 2022. [PMID: 36174581 DOI: 10.1055/a-1909-1196] [Reference Citation Analysis]
8 Azhar A, Naseem Z, Haider G, Farooqui N, Farhat S, Rehman R. PCOS model: Apoptotic changes and role of vitamin D. ELECTRON J GEN MED 2022;19:em398. [DOI: 10.29333/ejgm/12275] [Reference Citation Analysis]
9 Sutaji Z, Elias MH, Ahmad MF, Karim AKA, Abu MA. A Systematic Review and Integrated Bioinformatic Analysis of Candidate Genes and Pathways in the Endometrium of Patients With Polycystic Ovary Syndrome During the Implantation Window. Front Endocrinol 2022;13:900767. [DOI: 10.3389/fendo.2022.900767] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kumar R, Minerva S, Shah R, Bhat A, Verma S, Chander G, Bhat GR, Thapa N, Bhat A, Wakhloo A, Ganie MA. Role of genetic, environmental, and hormonal factors in the progression of PCOS: A review. JRHM 2022;3:3. [DOI: 10.25259/jrhm_16_2021] [Reference Citation Analysis]
11 Gleicher N, Darmon S, Patrizio P, Barad DH. Reconsidering the Polycystic Ovary Syndrome (PCOS). Biomedicines 2022;10:1505. [DOI: 10.3390/biomedicines10071505] [Reference Citation Analysis]
12 Wang H, Li H, Zhu J, Xu J, Jiang Y, Chen W, Sun Y, Yang Q. The Effect of Sperm DNA Fragmentation on In Vitro Fertilization Outcomes for Women With Polycystic Ovary Syndrome. Front Endocrinol (Lausanne) 2022;13:822786. [PMID: 35712248 DOI: 10.3389/fendo.2022.822786] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Rudic J, Jakovljevic V, Jovic N, Nikolic M, Sretenovic J, Mitrovic S, Bolevich S, Bolevich S, Mitrovic M, Raicevic S, Andric K, Dimkic Milenkovic A, Rakic D, Joksimovic Jovic J. Antioxidative Effects of Standardized Aronia melanocarpa Extract on Reproductive and Metabolic Disturbances in a Rat Model of Polycystic Ovary Syndrome. Antioxidants 2022;11:1099. [DOI: 10.3390/antiox11061099] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Siemienowicz KJ, Filis P, Thomas J, Fowler PA, Duncan WC, Rae MT. Hepatic Mitochondrial Dysfunction and Risk of Liver Disease in an Ovine Model of “PCOS Males”. Biomedicines 2022;10:1291. [DOI: 10.3390/biomedicines10061291] [Reference Citation Analysis]
15 Alhassan SM, Elmugadam A, Abubaker NE, Elfadil GA. Testosterone level correlates significantly with luteinizing hormone to follicle-stimulating hormone ratio among women with polycystic ovary syndrome: A cross sectional study. F1000Res 2022;11:152. [DOI: 10.12688/f1000research.76220.2] [Reference Citation Analysis]
16 Mir R, Saeedi NH, Jalal MM, Altayar MA, Barnawi J, Hamadi A, Tayeb FJ, Alshammari SE, Mtiraoui N, M. Ali ME, Abuduhier FM, Ullah MF. Clinical Implications of Krüpple-like Transcription Factor KLF-14 and Certain Micro-RNA (miR-27a, miR-196a2, miR-423) Gene Variations as a Risk Factor in the Genetic Predisposition to PCOS. JPM 2022;12:586. [DOI: 10.3390/jpm12040586] [Reference Citation Analysis]
17 Wang C, Zhang Y. Endoplasmic Reticulum Stress: A New Research Direction for Polycystic Ovary Syndrome? DNA Cell Biol 2022. [PMID: 35353637 DOI: 10.1089/dna.2021.1050] [Reference Citation Analysis]
18 Mir R, Tayeb FJ, Barnawi J, Jalal MM, Saeedi NH, Hamadi A, Altayar MA, Alshammari SE, Mtiraoui N, Ali ME, Duhier FMA, Ullah MF. Biochemical Characterization and Molecular Determination of Estrogen Receptor-α (ESR1 PvuII-rs2234693 T>C) and MiRNA-146a (rs2910164 C>G) Polymorphic Gene Variations and Their Association with the Risk of Polycystic Ovary Syndrome. IJERPH 2022;19:3114. [DOI: 10.3390/ijerph19053114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Farhadi-azar M, Behboudi-gandevani S, Rahmati M, Mahboobifard F, Khalili Pouya E, Ramezani Tehrani F, Azizi F. The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study. Front Endocrinol 2022;13:825528. [DOI: 10.3389/fendo.2022.825528] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Rodier C, Courbière B, Fernandes S, Vermalle M, Florence B, Resseguier N, Brue T, Cuny T. Metoclopramide Test in Hyperprolactinemic Women With Polycystic Ovarian Syndrome: Old Wine Into New Bottles? Front Endocrinol 2022;13:832361. [DOI: 10.3389/fendo.2022.832361] [Reference Citation Analysis]
21 Alhassan SM, Elmugadam A, Abubaker NE, Elfadil GA. Testosterone level correlates significantly with luteinizing hormone to follicle-stimulating hormone ratio among women with polycystic ovary syndrome: A cross sectional study. F1000Res 2022;11:152. [DOI: 10.12688/f1000research.76220.1] [Reference Citation Analysis]
22 Adamyan LV, Andreeva EN, Absatarova YS, Grigoryan OR, Dedov II, Melnichenko GA, Suturina LV, Filippov OS, Sheremetyeva EV, Chernukha GE, Yarmolinskaya MI. Clinical guidelines «Polycystic Ovary Syndrome». Probl Endokrinol (Mosk) 2022;68:112-127. [DOI: 10.14341/probl12874] [Reference Citation Analysis]
23 Papadimitriou K, Anagnostis P, Goulis DG. The challenging role of antiandrogens in the management of polycystic ovary syndrome. Polycystic Ovary Syndrome 2022. [DOI: 10.1016/b978-0-12-823045-9.00013-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Diamanti-kandarakis E, Papalou O, Kandaraki E. Endocrine-disrupting chemicals and PCOS: A novel contributor in the etiology of the syndrome. Polycystic Ovary Syndrome 2022. [DOI: 10.1016/b978-0-12-823045-9.00015-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Di Bari F, Benvenga S. Vitamin D metabolism in polycystic ovary syndrome (PCOS). Polycystic Ovary Syndrome 2022. [DOI: 10.1016/b978-0-12-823045-9.00004-3] [Reference Citation Analysis]
26 Abdelhamed MH, Al-ghamdi WM, Al-agha AE. Polycystic Ovary Syndrome Among Female Adolescents With Congenital Adrenal Hyperplasia. Cureus 2021. [DOI: 10.7759/cureus.20698] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Soodi S, Keshavarz SA, Hosseini S, Abbasi B. Dietary diversity score is inversely related to the risk of polycystic ovary syndrome in Tehranian women: a case-control study. Appl Physiol Nutr Metab 2021;:1-6. [PMID: 34878921 DOI: 10.1139/apnm-2021-0359] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Haslan MA, Samsulrizal N, Hashim N, Zin NSNM, Shirazi FH, Goh YM. Ficus deltoidea ameliorates biochemical, hormonal, and histomorphometric changes in letrozole-induced polycystic ovarian syndrome rats. BMC Complement Med Ther 2021;21:291. [PMID: 34844580 DOI: 10.1186/s12906-021-03452-6] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
29 Westerman R, Kuhnt AK. Metabolic risk factors and fertility disorders: A narrative review of the female perspective. Reprod Biomed Soc Online 2022;14:66-74. [PMID: 34765754 DOI: 10.1016/j.rbms.2021.09.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
30 Zaydiyeva ZS, Uruymagova AT. Polycystic ovarian syndrome: current understanding of pathogenesis, diagnosis and treatment. Medicinskij sovet 2021. [DOI: 10.21518/2079-701x-2021-13-102-111] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Zhao H, Xing C, Zhang J, He B. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis. Reprod Health 2021;18:171. [PMID: 34407851 DOI: 10.1186/s12978-021-01207-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
32 Dong S, Jiao J, Jia S, Li G, Zhang W, Yang K, Wang Z, Liu C, Li D, Wang X. 16S rDNA Full-Length Assembly Sequencing Technology Analysis of Intestinal Microbiome in Polycystic Ovary Syndrome. Front Cell Infect Microbiol 2021;11:634981. [PMID: 34041041 DOI: 10.3389/fcimb.2021.634981] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
33 Kalyanaraman R, Pal L. A Narrative Review of Current Understanding of the Pathophysiology of Polycystic Ovary Syndrome: Focus on Plausible Relevance of Vitamin D. Int J Mol Sci 2021;22:4905. [PMID: 34063169 DOI: 10.3390/ijms22094905] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Monastra G, Vucenik I, Harrath AH, Alwasel SH, Kamenov ZA, Laganà AS, Monti N, Fedeli V, Bizzarri M. PCOS and Inositols: Controversial Results and Necessary Clarifications. Basic Differences Between D-Chiro and Myo-Inositol. Front Endocrinol (Lausanne) 2021;12:660381. [PMID: 33889133 DOI: 10.3389/fendo.2021.660381] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
35 Annie L, Gurusubramanian G, Roy VK. Inhibition of visfatin by FK866 mitigates pathogenesis of cystic ovary in letrozole-induced hyperandrogenised mice. Life Sci 2021;276:119409. [PMID: 33781825 DOI: 10.1016/j.lfs.2021.119409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
36 Di Bari F, Catalano A, Bellone F, Martino G, Benvenga S. Vitamin D, Bone Metabolism, and Fracture Risk in Polycystic Ovary Syndrome. Metabolites 2021;11:116. [PMID: 33670644 DOI: 10.3390/metabo11020116] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
37 Le Magueresse-Battistoni B. Adipose Tissue and Endocrine-Disrupting Chemicals: Does Sex Matter? Int J Environ Res Public Health 2020;17:E9403. [PMID: 33333918 DOI: 10.3390/ijerph17249403] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
38 Kamenov Z, Gateva A. Inositols in PCOS. Molecules 2020;25:E5566. [PMID: 33260918 DOI: 10.3390/molecules25235566] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
39 Seow KM, Chang YW, Chen KH, Juan CC, Huang CY, Lin LT, Tsui KH, Chen YJ, Lee WL, Wang PH. Molecular Mechanisms of Laparoscopic Ovarian Drilling and Its Therapeutic Effects in Polycystic Ovary Syndrome. Int J Mol Sci 2020;21:E8147. [PMID: 33142702 DOI: 10.3390/ijms21218147] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]